close icon-linkedin icon-twitter icon-facebook icon-mail icon-google-plus icon-search icon-phone icon-instagram
Wat zoekt u?
Artikel 1 mei 2015

Protecting personalized medicine at the EPO

Geschreven door Caroline Pallard
Dit artikel is alleen beschikbaar in het Engels. Under Article 54(5) of the European Patent Convention (EPC) 2000, known substances or compositions are deemed to be novel if they are intended for specific use in a medical method and such use is not comprised in the state of the art (i.e., second or further medical use).

This article was first published in IAM Life Sciences 2015.

Article: Protecting personalised medicine at the EPO
pdf - 381.17 KB